| 000 | 00917nam a22002657a 4500 | ||
|---|---|---|---|
| 003 | BD-DhUL | ||
| 005 | 20191024142718.0 | ||
| 008 | 191023s2014 flua|||| b||| 001 0 eng | ||
| 020 | _a9781439867945 (hbk) | ||
| 040 |
_aBD-DhUL _cBD-DhUL |
||
| 082 |
_a615.7040287 _bBEN |
||
| 245 | 1 | 0 |
_aBenefit-risk assessment in pharmaceutical research and development / _cedited by Andreas Sashegyi, James Felli, and Rebecca Noel. |
| 260 |
_aBoca Raton : _bCRC Press, _c2014. |
||
| 300 |
_axxii, 194 p. : _bill. (some col.) ; _c24 cm. |
||
| 365 |
_aGBP _b68.99 |
||
| 490 | 0 | _aChapman &Hall/CRC biostatistics series | |
| 504 | _aGlossary: p. 185-186. | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 | _aDrugs - Testing. | |
| 650 | 0 | _aHealth risk assessment. | |
| 700 | 1 |
_aSashegyi, Andreas. _eed. |
|
| 700 | 1 |
_aFelli,James. _ejt. ed. |
|
| 700 | 1 |
_aNoel, Rebecca. _ejt. ed. |
|
| 942 |
_2ddc _cBK |
||
| 999 |
_c250483 _d250483 |
||